Maravai LifeSciences Holdings reported third quarter 2026 sales of US$45.85 million and a net loss of US$13.84 million, with nine month sales of US$163.13 million and a loss of US$29.99 million. Both ...
Source LinkMaravai LifeSciences Holdings reported third quarter 2026 sales of US$45.85 million and a net loss of US$13.84 million, with nine month sales of US$163.13 million and a loss of US$29.99 million. Both ...
Source Link
Comments